Sichuan University

This study tests whether combining targeted radiation with immunotherapy drugs before surgery can better eliminate lung cancer tumors. It involves 30 adults with stage II-III non-small cell lung cancer who are eligible for surgery. The goal is to see if this combination treatment…

This study is testing if adding two types of radiation therapy to a standard first-line treatment works better for people with advanced squamous cell lung cancer. The standard treatment is an immunotherapy drug (sintilimab) plus chemotherapy. Researchers want to see if adding rad…

This study is testing if adding a new immunotherapy drug (adebrelimab) and a low dose of radiation to standard chemotherapy works better for people with advanced small cell lung cancer that has spread. It will involve about 202 patients who haven't had prior treatment for this ad…

This early-stage study is testing the safety of a new combination treatment for patients with large, advanced solid tumors that have not responded to standard therapies. The treatment combines two types of targeted radiation with an immunotherapy drug (tislelizumab) that helps th…

This study is testing a three-part treatment for advanced esophageal cancer that cannot be removed by surgery right away. It combines a modified virus designed to attack cancer cells with standard chemotherapy and an immunotherapy drug. The main goals are to see if this combinati…